News
U.S. warns of liver risk with Glaxo, Roche diet drugs (Reuters)
May 26, 2010 by publisher · Leave a Comment
Reuters – Weight-loss drugs from GlaxoSmithKline PLC and Roche Holding AG will carry new warnings about rare reports of liver injury, U.S. health officials said on Wednesday.
Here is the original post:
U.S. warns of liver risk with Glaxo, Roche diet drugs
(Reuters)